CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ·Healthcare·Biotechnology
$0.39
-4.85%
Mkt Cap $8.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $2.08M | $60.00K | -97.11% | -$0.30 | -$0.67 | -125.06% | — | — |
| Q4 2025 Nov 26, 2025 | $6.77M | $77.00K | -98.86% | $0.38 | -$0.27 | -171.05% | — | — |
| Q3 2025 Aug 20, 2025 | $16.53M | $179.00K | -98.92% | -$0.10 | -$0.28 | -180.00% | — | — |
| Q2 2025 May 28, 2025 | $8.91M | $2.06M | -76.94% | -$0.37 | -$0.13 | +64.86% | — | — |
| Q1 2025 Mar 26, 2025 | $100.00K | $164.00K | +64.00% | -$0.42 | -$0.34 | +19.05% | — | — |
| Q4 2024 Nov 27, 2024 | $364.91K | $4.00K | -98.90% | -$0.28 | -$0.38 | -35.71% | — | — |
| Q3 2024 Aug 20, 2024 | $420.00K | $249.00K | -40.71% | -$0.35 | -$0.37 | -5.71% | — | — |
| Q2 2024 Apr 4, 2024 | $600.00K | $98.00K | -83.67% | -$0.35 | -$0.42 | -20.00% | — | — |
| Q1 2024 Jan 25, 2024 | $4.34M | $299.00K | -93.11% | -$0.07 | -$0.24 | -242.86% | — | — |
| Q4 2023 Nov 29, 2023 | $4.34M | $43.00K | -99.01% | -$0.13 | -$0.38 | -192.31% | — | — |
| Q3 2023 Aug 24, 2023 | $190.00K | $10.18M | +5260.00% | $0.01 | $0.49 | +3166.67% | — | — |
| Q2 2023 May 24, 2023 | $240.00K | $433.00K | +80.42% | -$0.29 | -$0.33 | -13.79% | — | — |
| Q1 2023 Mar 29, 2023 | $50.00K | $58.00K | +16.00% | -$0.21 | -$0.39 | -85.71% | — | — |
| Q4 2022 Dec 1, 2022 | $3.10M | $109.00K | -96.48% | -$0.31 | -$0.40 | -29.03% | — | — |
| Q3 2022 Aug 25, 2022 | $2.86M | $66.00K | -97.69% | -$0.08 | -$0.39 | -387.50% | — | — |
| Q2 2022 May 26, 2022 | $2.74M | $66.00K | -97.59% | -$0.14 | -$0.36 | -157.14% | — | — |
| Q1 2022 Mar 24, 2022 | $338.00K | $310.00K | -8.28% | -$0.26 | -$0.30 | -15.38% | — | — |
| Q4 2021 Nov 18, 2021 | $21.12M | $140.00K | -99.34% | -$0.28 | -$0.29 | -3.57% | — | — |
| Q3 2021 Aug 19, 2021 | — | $691.00K | — | -$0.10 | -$0.30 | -200.00% | — | — |
| Q2 2021 May 27, 2021 | — | $14.50M | — | $0.51 | $0.88 | +72.55% | — | — |